Skip to main content
. 2001 Feb 15;531(Pt 1):235–244. doi: 10.1111/j.1469-7793.2001.0235j.x

Table 1. Time-domain results.

RR(ms) RR variance (ms2) SP(mmHg) SP variance(mmHg2) DP(mmHg) DP variance(mmHg2) MP(mmHg) MP variance(mmHg2)
Control 768 ± 85 1331 ± 380 142 ± 11 26.6 ± 21.1 78 ± 9 7.7 ± 2.5 100 ± 12 11.3 ± 3.9
Treatment 712 ± 95 841 ± 567 126 ± 10 12.0 ± 10.4 73 ± 8 5.7 ± 5.7 93 ± 11 7.7 ± 7.6
P 0.16 0.047 0.0001 0.18 0.1 0.23 0.15 0.34

Mean values ± s.d. of heart period (RR), systolic (SP), diastolic (DP) and mean (MP) arterial pressure, and their respective variance in 8 subjects, before (Control) and during administration of urapidil and angiotensin II (Treatment). P, statistical significance of changes between control and treatment by paired t test.